Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, Maillard J N, Pariente E A, Leporrier M, Rueff B
Ann Intern Med. 1985 Sep;103(3):329-34. doi: 10.7326/0003-4819-103-3-329.
We assessed the prevalence of overt and latent primary myeloproliferative disorders in hepatic vein thrombosis. Cultures of bone marrow or peripheral blood mononuclear cells were done in 20 patients with Budd-Chiari syndrome. Erythroid colony formation in the absence of erythropoietin, which is a reliable indicator for a primary myeloproliferative disorder, was seen in 16 patients in whom Budd-Chiari syndrome was due to hepatic vein thrombosis, including 13 women aged 18 to 45 years. Among these 16 patients, the conventional criteria for the diagnosis of a primary myeloproliferative disorder were met in only 2. Primary myeloproliferative disorder, often without peripheral blood changes, is a major cause of hepatic vein thrombosis in young women.
我们评估了肝静脉血栓形成中显性和潜伏性原发性骨髓增殖性疾病的患病率。对20例布加综合征患者进行了骨髓或外周血单个核细胞培养。在16例因肝静脉血栓形成导致布加综合征的患者中观察到在无促红细胞生成素情况下的红系集落形成,这是原发性骨髓增殖性疾病的可靠指标,其中包括13名年龄在18至45岁的女性。在这16例患者中,仅2例符合原发性骨髓增殖性疾病的传统诊断标准。原发性骨髓增殖性疾病通常无外周血变化,是年轻女性肝静脉血栓形成的主要原因。